133 related articles for article (PubMed ID: 34547877)
1. [Characteristics of immunoglobulin heavy-chain gene clonal rearrangements by next-generation sequencing of patients with multiple myeloma].
Yao L; Chen Y; Zhai YY; Shi XL; Cen JN; Yan LZ; Fu CC; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):683-686. PubMed ID: 34547877
[No Abstract] [Full Text] [Related]
2. Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.
Medina A; Jiménez C; Sarasquete ME; González M; Chillón MC; Balanzategui A; Prieto-Conde I; García-Álvarez M; Puig N; González-Calle V; Alcoceba M; Cuenca I; Barrio S; Escalante F; Gutiérrez NC; Gironella M; Hernández MT; Sureda A; Oriol A; Bladé J; Lahuerta JJ; San Miguel JF; Mateos MV; Martínez-López J; Calasanz MJ; García-Sanz R
Blood Cancer J; 2020 Feb; 10(2):14. PubMed ID: 32029700
[TBL] [Abstract][Full Text] [Related]
3. Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma.
Rustad EH; Misund K; Bernard E; Coward E; Yellapantula VD; Hultcrantz M; Ho C; Kazandjian D; Korde N; Mailankody S; Keats JJ; Akhlaghi T; Viny AD; Mayman DJ; Carroll K; Patel M; Famulare CA; Op Bruinink DH; Hutt K; Jacobsen A; Huang Y; Miller JE; Maura F; Papaemmanuil E; Waage A; Arcila ME; Landgren O
Am J Hematol; 2019 Dec; 94(12):1364-1373. PubMed ID: 31571261
[TBL] [Abstract][Full Text] [Related]
4. Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.
Ching T; Duncan ME; Newman-Eerkes T; McWhorter MME; Tracy JM; Steen MS; Brown RP; Venkatasubbarao S; Akers NK; Vignali M; Moorhead ME; Watson D; Emerson RO; Mann TP; Cimler BM; Swatkowski PL; Kirsch IR; Sang C; Robins HS; Howie B; Sherwood A
BMC Cancer; 2020 Jun; 20(1):612. PubMed ID: 32605647
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases.
Hadzidimitriou A; Stamatopoulos K; Belessi C; Lalayianni C; Stavroyianni N; Smilevska T; Hatzi K; Laoutaris N; Anagnostopoulos A; Kollia P; Fassas A
Haematologica; 2006 Jun; 91(6):781-7. PubMed ID: 16769580
[TBL] [Abstract][Full Text] [Related]
6. Molecular features responsible for the absence of immunoglobulin heavy chain protein synthesis in an IgH(-) subgroup of multiple myeloma.
Szczepański T; van 't Veer MB; Wolvers-Tettero IL; Langerak AW; van Dongen JJ
Blood; 2000 Aug; 96(3):1087-93. PubMed ID: 10910926
[TBL] [Abstract][Full Text] [Related]
7. Deep sequencing reveals myeloma cells in peripheral blood in majority of multiple myeloma patients.
Vij R; Mazumder A; Klinger M; O'Dea D; Paasch J; Martin T; Weng L; Park J; Fiala M; Faham M; Wolf J
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):131-139.e1. PubMed ID: 24629890
[TBL] [Abstract][Full Text] [Related]
8. Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR.
González D; González M; Alonso ME; López-Pérez R; Balanzategui A; Chillón MC; Silva M; García-Sanz R; San Miguel JF
Leukemia; 2003 Jun; 17(6):1051-7. PubMed ID: 12764368
[TBL] [Abstract][Full Text] [Related]
9. Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma.
Yao Q; Bai Y; Orfao A; Kumar S; Chim CS
J Mol Diagn; 2020 May; 22(5):679-684. PubMed ID: 32151713
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS.
Scheijen B; Meijers RWJ; Rijntjes J; van der Klift MY; Möbs M; Steinhilber J; Reigl T; van den Brand M; Kotrová M; Ritter JM; Catherwood MA; Stamatopoulos K; Brüggemann M; Davi F; Darzentas N; Pott C; Fend F; Hummel M; Langerak AW; Groenen PJTA;
Leukemia; 2019 Sep; 33(9):2227-2240. PubMed ID: 31197258
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the immunoglobulin code in multiple myeloma.
Szczepanski T
Haematologica; 2006 Jun; 91(6):725B. PubMed ID: 16769570
[No Abstract] [Full Text] [Related]
12. A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma.
Bolli N; Li Y; Sathiaseelan V; Raine K; Jones D; Ganly P; Cocito F; Bignell G; Chapman MA; Sperling AS; Anderson KC; Avet-Loiseau H; Minvielle S; Campbell PJ; Munshi NC
Blood Cancer J; 2016 Sep; 6(9):e467. PubMed ID: 27588520
[TBL] [Abstract][Full Text] [Related]
13. Clonal identities and multiple isotype transcripts in hematological diseases revealed by a single-strand conformation polymorphism analysis of the immunoglobulin heavy chain messenger signals.
Shiokawa S; Nishimura J; Uike N; Saburi Y; Suehiro T; Yamamoto K
Am J Hematol; 1999 Oct; 62(2):74-81. PubMed ID: 10509000
[TBL] [Abstract][Full Text] [Related]
14. Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.
Shin S; Hwang IS; Kim J; Lee KA; Lee ST; Choi JR
Ann Lab Med; 2017 Jul; 37(4):331-335. PubMed ID: 28445014
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin rearrangement analysis from multiple lesions in the same patient using next-generation sequencing.
Appenzeller S; Gilissen C; Rijntjes J; Tops BB; Kastner-van Raaij A; Hebeda KM; Nissen L; Dutilh BE; van Krieken JH; Groenen PJ
Histopathology; 2015 Dec; 67(6):843-58. PubMed ID: 25891511
[TBL] [Abstract][Full Text] [Related]
16. The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatment.
Rasmussen T; Jensen L; Johnsen HE
Leuk Lymphoma; 2002 May; 43(5):1075-7. PubMed ID: 12148889
[TBL] [Abstract][Full Text] [Related]
17. Detection of cells with clone-specific immunoglobulin gene rearrangements in the peripheral blood of myeloma patients using immunoglobulin gene fingerprinting.
Bird JM; Wilmore HP; Samson D
Eur J Haematol; 1996 Apr; 56(4):259-61. PubMed ID: 8641398
[No Abstract] [Full Text] [Related]
18. Molecular analysis of immunoglobulin genes in multiple myeloma.
Kosmas C; Stamatopoulos K; Stavroyianni N; Belessi C; Viniou N; Yataganas X
Leuk Lymphoma; 1999 Apr; 33(3-4):253-65. PubMed ID: 10221505
[TBL] [Abstract][Full Text] [Related]
19. Distinctive features of immunoglobulin heavy chain variable region gene rearrangement in multiple myeloma.
Baker BW; Deane M; Gilleece MH; Johnston D; Scarffe JH; Norton JD
Leuk Lymphoma; 1994 Jul; 14(3-4):291-301. PubMed ID: 7950918
[TBL] [Abstract][Full Text] [Related]
20. The use of fluorescent molecular beacons in real time PCR of IgH gene rearrangements for quantitative evaluation of multiple myeloma.
Martínez-López J; Lahuerta JJ; Salama P; Ayala R; Bautista JM
Clin Lab Haematol; 2004 Feb; 26(1):31-5. PubMed ID: 14738435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
